ChemDiv Expands Modeling & Simulation Services Platform, Signs Tenth Collaborator in 2026 - Mondego Bio
FOR IMMEDIATE RELEASE
ChemDiv Expands Modeling & Simulation Services Platform, Signs Tenth Collaborator in 2026 - Mondego Bio
ChemDiv today announced the continued expansion of its Modeling & Simulation Services platform, highlighted by the signing of its tenth collaborator in 2026, Mondego Bio (Coimbra, Portugal), further demonstrating growing industry adoption of Model-Informed Drug Development (MIDD) solutions.
Comment from Mondego Bio
"As Mondego Bio advances its lead immuno-oncology program toward the clinic, we recognize the growing importance of Model-Informed Drug Development in supporting key translational and clinical decisions. ChemDiv's expertise provides valuable support to our strategy and strengthens our efforts to build a robust and data-driven development program."
— Rita Santos, External Outreach Director, Mondego Bio
Operating at the intersection of clinical pharmacology, quantitative sciences, and advanced computational modeling, ChemDiv's Modeling & Simulation Services provide integrated support across all stages of drug development - from candidate nomination and first-in-human studies through late-stage clinical development and regulatory submission.
Comment from ChemDiv, Inc
"Model-Informed Drug Development is transforming how therapies are developed and evaluated. Our goal is to help partners leverage quantitative science to make better decisions earlier, reduce uncertainty, and increase the probability of success."
— Roman Timakhov, Research Director, ChemDiv, Inc
By integrating mechanistic modeling, quantitative pharmacology, and advanced simulation techniques, ChemDiv provides a comprehensive framework for evidence-based decision-making throughout drug development.
Empower Drug Development with ChemDiv's Modeling & Simulation Services
Our integrated service offerings include:
Pharmacometrics & PK/PD Analysis
Population pharmacokinetic (PopPK) modeling
Exposure-response analysis
Dose optimization and dose justification
Clinical trial simulation
Model-Informed Drug Development (MIDD)
PBPK & PBBM Modeling
First-in-human dose prediction
Drug-drug interaction assessment
Food-effect evaluation
Formulation bridging
Special population modeling
Quantitative Systems Pharmacology (QSP)
Mechanistic disease modeling
Virtual patient simulations
Biomarker strategy development
Translational pharmacology
Combination therapy assessment
Clinical Pharmacology & Regulatory Support
Clinical pharmacology strategy
Regulatory submission support
FDA and EMA MIDD interactions
Clinical study design optimization
Enabling Better Development Decisions
ChemDiv's Modeling & Simulation Services are designed to help partners:
Accelerate clinical development timelines
Improve confidence in dose selection
Reduce development risk
Optimize clinical trial design
Support regulatory decision-making
Minimize unnecessary clinical studies
About ChemDiv
ChemDiv is a fully integrated discovery & development partner from target to clinic, offering one of the industry’s largest discovery ecosystems: 12M+ screening compounds, thousands of targeted tool libraries, ~70,000 building blocks, and a catalog of ~45,000 inhibitors and drugs. Services span custom medicinal chemistry, AI-powered CADD, computational and experimental pharmacology, ADME/DMPK, translational biology, CMC/process research, and clinical pharmacology support. ChemDiv operates globally with teams across the U.S. and Europe, enabling seamless discovery-to-development execution for biotech and pharma partners.
About Mondego Bio
Mondego Bio is a biotechnology company based in Coimbra, Portugal, focused on developing best-in-class PTPN2 inhibitors for cancer immunotherapy. By targeting key immune-regulatory pathways, the company aims to enhance anti-tumor immune responses and develop next-generation immuno-oncology therapies with improved efficacy, safety, and tolerability.
Media/Partner Inquiries
ChemDiv
12730 High Bluff Dr, Suite 100, San Diego, CA 92130 USA
+1 8587944860 • chemdiv@chemdiv.com
